CO6640213A2 - Comprimido de desintegración por vía oral que contiene acarbosa - Google Patents
Comprimido de desintegración por vía oral que contiene acarbosaInfo
- Publication number
- CO6640213A2 CO6640213A2 CO12192234A CO12192234A CO6640213A2 CO 6640213 A2 CO6640213 A2 CO 6640213A2 CO 12192234 A CO12192234 A CO 12192234A CO 12192234 A CO12192234 A CO 12192234A CO 6640213 A2 CO6640213 A2 CO 6640213A2
- Authority
- CO
- Colombia
- Prior art keywords
- disintegration tablet
- oral disintegration
- tablet containing
- acarbose
- containing acarbose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Era un objeto de la presente invención proporcionar un comprimido de desintegración por vía oral (ODT) para el inhibidor de la glucosidasa acarbosa. El objetivo se consigue con un comprimido de desintegración por vía oral que contiene un 1-30 % de acarbosa y un 40-90 % de vehículo soluble en agua.Con el fin de obtener las propiedades deseadas, se tienen que compactar previamente los ingredientes y mezclar previamente con un vehículo insoluble.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10161114 | 2010-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6640213A2 true CO6640213A2 (es) | 2013-03-22 |
Family
ID=44344015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO12192234A CO6640213A2 (es) | 2010-04-27 | 2012-10-26 | Comprimido de desintegración por vía oral que contiene acarbosa |
Country Status (26)
Country | Link |
---|---|
US (1) | US20130131003A1 (es) |
EP (1) | EP2563329B1 (es) |
JP (1) | JP5944378B2 (es) |
KR (1) | KR101788350B1 (es) |
CN (2) | CN106924199A (es) |
AU (1) | AU2011247642C1 (es) |
BR (1) | BR112012027303A2 (es) |
CA (1) | CA2797365A1 (es) |
CL (1) | CL2012003011A1 (es) |
CO (1) | CO6640213A2 (es) |
CR (1) | CR20120548A (es) |
CU (1) | CU20120152A7 (es) |
DO (1) | DOP2012000277A (es) |
EC (1) | ECSP12012279A (es) |
ES (1) | ES2623025T3 (es) |
GT (1) | GT201200290A (es) |
IL (1) | IL222368B (es) |
MX (1) | MX348865B (es) |
MY (1) | MY179724A (es) |
NZ (1) | NZ603199A (es) |
PE (1) | PE20130403A1 (es) |
SG (2) | SG184851A1 (es) |
SI (1) | SI2563329T1 (es) |
TW (1) | TWI556823B (es) |
UA (1) | UA111155C2 (es) |
WO (1) | WO2011134962A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201100150A2 (tr) * | 2011-01-06 | 2012-07-23 | Bi̇lgi̇ç Mahmut | Suda çözünür dozaj formları |
WO2013115738A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Micronized acarbose |
WO2013115741A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Pharmaceutical compositions comprising alpha-glucosidase inhibitor |
CA2922849A1 (en) * | 2012-08-31 | 2014-03-06 | Ixchel Pharma, Llc | Agents useful for treating obesity, diabetes and related disorders |
CN104013590A (zh) * | 2014-05-09 | 2014-09-03 | 万特制药(海南)有限公司 | 一种含阿卡波糖的药物组合物及其制备方法 |
WO2016097170A1 (en) * | 2014-12-17 | 2016-06-23 | Empros Pharma Ab | A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders |
CN105213341A (zh) * | 2015-10-29 | 2016-01-06 | 无锡福祈制药有限公司 | 一种阿卡波糖片及其制备方法 |
CN113081984B (zh) * | 2021-04-19 | 2023-06-02 | 北京阳光诺和药物研究股份有限公司 | 一种阿卡波糖口崩片及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3134591A1 (de) * | 1981-09-01 | 1983-03-10 | Bayer Ag, 5090 Leverkusen | Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren |
JPH10182687A (ja) * | 1996-10-21 | 1998-07-07 | Bayer Yakuhin Kk | アカルボースの貯蔵安定化法 |
DE19802700A1 (de) * | 1998-01-24 | 1999-07-29 | Bayer Ag | Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält |
US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
KR100682836B1 (ko) * | 2004-12-06 | 2007-02-15 | 엘지전자 주식회사 | 유기 전계 발광 소자 |
US20060229261A1 (en) * | 2005-04-12 | 2006-10-12 | John Devane | Acarbose methods and formulations for treating chronic constipation |
MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
JP4931907B2 (ja) * | 2006-02-27 | 2012-05-16 | パナソニック株式会社 | ウェアラブル端末、および、携帯撮像収音装置、およびそれらを実現する装置、方法、プログラム |
FI20070521L (fi) * | 2006-11-10 | 2008-05-11 | Atacama Labs Oy | Rakeita, tabletteja ja rakeistusmenetelmä |
CN101411715B (zh) * | 2007-10-19 | 2012-03-28 | 杭州华东医药集团生物工程研究所有限公司 | 含有阿卡波糖的药物组合物 |
JP5291324B2 (ja) * | 2007-11-01 | 2013-09-18 | 沢井製薬株式会社 | 口腔内崩壊錠 |
JP2009114113A (ja) * | 2007-11-06 | 2009-05-28 | Nipro Corp | 口腔内崩壊錠及びその製造方法 |
JP2011506279A (ja) * | 2007-12-08 | 2011-03-03 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 経口で分散可能な錠剤 |
RU2524638C2 (ru) * | 2007-12-21 | 2014-07-27 | Апталис Фарматех Инк. | Орально распадающиеся таблеточные композиции темазепама |
RU2519768C2 (ru) * | 2008-06-20 | 2014-06-20 | Мерк Патент Гмбх | Поддающаяся прямому прессованию и быстро распадающаяся матрица таблетки |
-
2011
- 2011-04-26 TW TW100114368A patent/TWI556823B/zh not_active IP Right Cessation
- 2011-04-26 UA UAA201213526A patent/UA111155C2/uk unknown
- 2011-04-26 MY MYPI2012700818A patent/MY179724A/en unknown
- 2011-04-26 SI SI201131170A patent/SI2563329T1/sl unknown
- 2011-04-26 PE PE2012002079A patent/PE20130403A1/es not_active Application Discontinuation
- 2011-04-26 CN CN201610934162.1A patent/CN106924199A/zh active Pending
- 2011-04-26 ES ES11716264.4T patent/ES2623025T3/es active Active
- 2011-04-26 KR KR1020127028046A patent/KR101788350B1/ko active IP Right Grant
- 2011-04-26 CN CN2011800205487A patent/CN102905687A/zh active Pending
- 2011-04-26 NZ NZ603199A patent/NZ603199A/en not_active IP Right Cessation
- 2011-04-26 AU AU2011247642A patent/AU2011247642C1/en not_active Ceased
- 2011-04-26 EP EP11716264.4A patent/EP2563329B1/en active Active
- 2011-04-26 WO PCT/EP2011/056587 patent/WO2011134962A2/en active Application Filing
- 2011-04-26 BR BR112012027303A patent/BR112012027303A2/pt not_active IP Right Cessation
- 2011-04-26 SG SG2012076147A patent/SG184851A1/en unknown
- 2011-04-26 SG SG10201505844WA patent/SG10201505844WA/en unknown
- 2011-04-26 US US13/643,929 patent/US20130131003A1/en not_active Abandoned
- 2011-04-26 CA CA2797365A patent/CA2797365A1/en not_active Abandoned
- 2011-04-26 MX MX2012012459A patent/MX348865B/es active IP Right Grant
- 2011-04-26 JP JP2013506633A patent/JP5944378B2/ja active Active
-
2012
- 2012-10-11 IL IL222368A patent/IL222368B/en active IP Right Grant
- 2012-10-25 CU CU2012000152A patent/CU20120152A7/es unknown
- 2012-10-26 CR CR20120548A patent/CR20120548A/es unknown
- 2012-10-26 DO DO2012000277A patent/DOP2012000277A/es unknown
- 2012-10-26 EC ECSP12012279 patent/ECSP12012279A/es unknown
- 2012-10-26 CO CO12192234A patent/CO6640213A2/es not_active Application Discontinuation
- 2012-10-26 GT GT201200290A patent/GT201200290A/es unknown
- 2012-10-26 CL CL2012003011A patent/CL2012003011A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6640213A2 (es) | Comprimido de desintegración por vía oral que contiene acarbosa | |
GT201400196A (es) | Compuestos de heterociclilo | |
CO6410279A2 (es) | Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente. | |
AR077199A1 (es) | Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia | |
GT201300137A (es) | Derivados de imidazo [1,2-b] piridazina e imidazo [4,5-b] piridina como inhibidores de jak | |
CO6771428A2 (es) | Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales | |
GT201200165A (es) | Triazolopiridinas | |
BR112012019529A2 (pt) | inibidores de d-nitrosoglutationa redutase | |
BR112014004460A2 (pt) | material polimérico para um recipiente isolado | |
DOP2015000170A (es) | Compuestos químicos | |
GT201500094A (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
UY34112A (es) | Composiciones farmacéuticas que contienen un agente neuroléptico y un inhibidor sglt2 y usos de los mismos | |
AR081670A1 (es) | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo | |
CO7091174A2 (es) | Compuestos triazolo como inhibidores de pde10 | |
BR112015008912A2 (pt) | composições solidificáveis compreendendo volastonita e pedra-pomes e métodos de uso | |
BR112015030431A2 (pt) | formulação de liberação modificada | |
BR112015027824A8 (pt) | formulação de vitamina e na forma de pó | |
ECSP12011837A (es) | Derivados de pirazol que modulan la estearoil-coa-desaturasa | |
AR089114A1 (es) | PREVENCION DE LOS EFECTOS ADVERSOS CAUSADOS POR LOS ANTICUERPOS BIESPECIFICOS EpCAMxCD3 | |
CL2011000621A1 (es) | Agente que contiene por lo menos un acido acilciclohexanodionacarboxilico y/o sus sales en combinacion con por lo menos un ester de acido acilciclohexanodionacarboxilico y su uso para mejorar el desarrollo de gramineas. | |
NI201300100A (es) | Derivados de tieno [2, 3-d] pirimidina y su uso para tratar arritmias | |
CR20120461A (es) | Hidrato del hidrobromuro de agomelatina y preparación de éste | |
CL2012001759A1 (es) | Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica. | |
BR112013027391A2 (pt) | formulação farmacêutica, frasco e kit | |
BR112012024239A2 (pt) | composição para tratamento de trombocitemia essencial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |